US Patent Issued to Meryx on April 15 for "Polymorphs of a kinase inhibitor, pharmaceutical compositions containing such a compound, preparation methods, and applications" (American, Chinese Inventors)

ALEXANDRIA, Va., June 5 -- United States Patent no. 12,275,737, issued on April 15, was assigned to Meryx Inc. (Chapel Hill, N.C.).

"Polymorphs of a kinase inhibitor, pharmaceutical compositions containing such a compound, preparation methods, and applications" was invented by Xiaodong Wang (Chapel Hill, N.C.), Weihe Zhang (Vestavia, Ala.), Xiangyong Liu (Zhejiang, China), Changlong Han (Zhejiang, China) and Zongquan Li (Zhejiang, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to new crystal forms of compound (trans)-4-((2-cyclopropylethyl)amino)-5-(4-((4-methylpiperazin-1-yl)methyl)phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl) cyclohexanol trihydrochloride, its hydrate, or solvate, as...